APOE ɛ4 Allele Testing and Risk of Alzheimer Disease

JAMA. 2021 Feb 2;325(5):484-485. doi: 10.1001/jama.2020.15085.
No abstract available

MeSH terms

  • Alzheimer Disease / diagnosis
  • Alzheimer Disease / genetics*
  • Apolipoprotein E4*
  • Biomarkers
  • Cognitive Dysfunction / diagnosis
  • Cognitive Dysfunction / genetics*
  • Cognitive Dysfunction / prevention & control
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Risk
  • Sensitivity and Specificity

Substances

  • Apolipoprotein E4
  • Biomarkers